- Home
- QNCX vs RBOT Comparison
QNCX vs RBOT Comparison
Compare QNCX & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- RBOT
- Stock Information
- Founded
- QNCX 2012
- RBOT 2014
- Country
- QNCX United States
- RBOT United States
- Employees
- QNCX N/A
- RBOT N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- RBOT Medical Specialities
- Sector
- QNCX Health Care
- RBOT Health Care
- Exchange
- QNCX Nasdaq
- RBOT Nasdaq
- Market Cap
- QNCX 100.4M
- RBOT 38.2M
- IPO Year
- QNCX 2019
- RBOT N/A
- Fundamental
- Price
- QNCX $1.85
- RBOT $5.98
- Analyst Decision
- QNCX Strong Buy
- RBOT Hold
- Analyst Count
- QNCX 6
- RBOT 1
- Target Price
- QNCX $8.00
- RBOT $7.00
- AVG Volume (30 Days)
- QNCX 438.4K
- RBOT 115.7K
- Earning Date
- QNCX 11-12-2025
- RBOT 11-11-2025
- Dividend Yield
- QNCX N/A
- RBOT N/A
- EPS Growth
- QNCX N/A
- RBOT N/A
- EPS
- QNCX N/A
- RBOT N/A
- Revenue
- QNCX N/A
- RBOT N/A
- Revenue This Year
- QNCX N/A
- RBOT N/A
- Revenue Next Year
- QNCX N/A
- RBOT N/A
- P/E Ratio
- QNCX N/A
- RBOT N/A
- Revenue Growth
- QNCX N/A
- RBOT N/A
- 52 Week Low
- QNCX $0.71
- RBOT $5.00
- 52 Week High
- QNCX $2.45
- RBOT $19.00
- Technical
- Relative Strength Index (RSI)
- QNCX 54.40
- RBOT 47.09
- Support Level
- QNCX $1.82
- RBOT $5.53
- Resistance Level
- QNCX $2.04
- RBOT $6.82
- Average True Range (ATR)
- QNCX 0.17
- RBOT 0.80
- MACD
- QNCX 0.01
- RBOT 0.06
- Stochastic Oscillator
- QNCX 44.65
- RBOT 29.21
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.